Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 29,865 shares at $139.52 ($4.2M) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Open-market sale of $4.2M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.63 | 1,565 | $215K | 5.2% |
| 2 | $137.63 | 1,565 | $215K | 5.2% |
| 3 | $138.60 | 3,235 | $448K | 10.8% |
| 4 | $139.52 | 9,599 | $1.3M | 32.2% |
| 5 | $139.52 | 9,599 | $1.3M | 32.2% |
| 6 | $140.38 | 1,701 |
| $239K |
| 5.7% |
| 7 | $140.38 | 1,701 | $239K | 5.7% |
| 8 | $141.31 | 800 | $113K | 2.7% |
| 9 | $142.47 | 100 | $14K | 0.3% |
| Total | $139.38 avg | 29,865 | $4.2M | 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |